Author:
Soltani Mozhgan,Farhadi Amin,Rajabi Sarah,Homayouni‐Tabrizi Masoud,Hussein Fatimah Sameer,Mohammadian Navid
Abstract
AbstractCrocin is a carotenoid compound in saffron with anti-cancer properties. However, its therapeutic application is limited by its low absorption, bioavailability, and stability, which can be overcome through nanocarrier delivery systems. This study used surface-modified Nano-crystalline cellulose (NCC) to deliver crocin to cancer cells. NCC modified with CTAB were loaded with crocin and then conjugated with folic acid (NCF-CR-NPs). The synthesized nanoparticles (NPs) were characterized using FTIR, XRD, DLS, and FESEM. The crystallinity index of NCC was 66.64%, higher than microcrystalline cellulose (61.4%). The crocin loading and encapsulation efficiency in NCF-CR-NPs were evaluated. Toxicity testing by MTT assay showed that NCF-CR-NPs had higher toxicity against various cancer cell lines, including colon cancer HT-29 cells (IC50 ~ 11.6 μg/ml), compared to free crocin. Fluorescent staining, flow cytometry, and molecular analysis confirmed that NCF-CR-NPs induced apoptosis in HT-29 cells by increasing p53 and caspase 8 expression. The antioxidant capacity of NCF-CR-NPs was also evaluated using ABTS and DPPH radical scavenging assays. NCF-CR-NPs exhibited high free radical scavenging ability, with an IC50 of ~ 46.5 μg/ml for ABTS. In conclusion, this study demonstrates the potential of NCF-CR-NPs to deliver crocin to cancer cells effectively. The NPs exhibited enhanced anti-cancer and antioxidant activities compared to free crocin, making them a promising nanocarrier system for crocin-based cancer therapy.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Park, W., Heo, Y.-J. & Han, D. K. New opportunities for nanoparticles in cancer immunotherapy. Biomater. Res. 22, 1–10 (2018).
2. Wang, R., Billone, P. S. & Mullett, W. M. Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials. J. Nanomater. 2013, 1–12 (2013).
3. Adair, J. H., Parette, M. P., Altınoglu, E. I. & Kester, M. Nanoparticulate alternatives for drug delivery. ACS Nano 4, 4967–4970 (2010).
4. Wang, X., Zhang, H. & Chen, X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2, 141 (2019).
5. Dogan, M. Assessment of mechanism involved in the apoptotic and anti-cancer activity of Quercetin and Quercetin-loaded chitosan nanoparticles. Med. Oncol. 39, 176 (2022).